Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1999-08-11
Original market date: See footnote 1
1968-12-31
Product name:
ILOSONE LIQUID 125MG/5ML
DIN:
00015474 Electronic product monograph is not available
Company:
ELI LILLY CANADA INC
SUITE 900
Exchange Tower, 130 King Street West
Toronto
Ontario
Canada
M5X 1B1
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.12.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01FA01 ERYTHROMYCIN
Active ingredient group (AIG) number:See footnote5
0105708005
Active ingredient(s) | Strength |
---|---|
ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) | 125 MG / 5 ML |